A carregar...
Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus
SGLT-2 inhibitors have recently emerged as an important class of oral drugs for treatment of type 2 diabetes mellitus, especially in patients with cardiovascular or renal impairment, recommended in all recent treatment guidelines. They have additional advantages of weight and blood pressure reductio...
Na minha lista:
| Publicado no: | Diabetol Int |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Singapore
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8172658/ https://ncbi.nlm.nih.gov/pubmed/34150432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00472-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|